Home > Income Statement > MEDICAMEN BIOTECH

MEDICAMEN BIOTECH
Revenue

    Back to Income Statement
MEDICAMEN BIOTECH is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for MEDICAMEN BIOTECH
Please provide your vote to see the results

MEDICAMEN BIOTECH Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹179 Cr₹141 Cr₹115 Cr₹11,271,608 Cr₹126 Cr

What is the latest Revenue of MEDICAMEN BIOTECH ?

The latest Revenue ratio of MEDICAMEN BIOTECH is ₹179 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹179 Cr
Mar2024₹141 Cr
Mar2023₹115 Cr
Mar2022₹11,271,608 Cr
Mar2021₹126 Cr

How is Revenue of MEDICAMEN BIOTECH Trending?

Years Revenue % Change
Mar2025 ₹179 Cr
27.29
Mar2024 ₹141 Cr
22.02
Mar2023 ₹115 Cr
-100.00
Mar2022 ₹11,271,608 Cr
8,980,974.92
Mar2021 ₹126 Cr -

Compare Revenue of peers of MEDICAMEN BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH ₹351.6 Cr 6.6% -5.7% -49.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,937.0 Cr 1.2% -7% 2.5% Stock Analytics
DIVIS LABORATORIES ₹165,359.0 Cr 1.8% 2.7% 17% Stock Analytics
TORRENT PHARMACEUTICALS ₹141,431.0 Cr 0.5% -4.8% 32.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,114.0 Cr 0.3% -4.5% 11.5% Stock Analytics
CIPLA ₹100,028.0 Cr 0.7% -5.8% -13.1% Stock Analytics


MEDICAMEN BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MEDICAMEN BIOTECH

6.6%

-5.7%

-49.6%

SENSEX

2.4%

3.2%

5.8%


You may also like the below Video Courses